HIV-1 gp120 Antibodies

Santa Cruz Biotechnology offers a broad range of HIV-1 gp120 monoclonal antibodies for various research applications. HIV-1 gp120 Antibodies are optimized for techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HIV-1 gp120 is a critical envelope glycoprotein that plays a key role in the virus's ability to infect host cells by facilitating attachment to CD4 receptors and co-receptors on T cells. Understanding the function of HIV-1 gp120 is essential for developing therapeutic strategies and vaccines against HIV. The study of HIV-1 gp120 provides insights into the mechanisms of viral entry and immune evasion. Research focused on HIV-1 gp120 continues to reveal new aspects of viral infection pathways and potential therapeutic targets. Investigating HIV-1 gp120 interactions with host cells advances our understanding of viral transmission and pathogenesis. The development of effective HIV treatments relies heavily on detailed molecular studies of HIV-1 gp120 structure and function. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in their mission to understand and combat HIV infection through precise and reliable experimental methods.